Role for NK(1) and NK(2) receptors in the motor activity in mouse colon

Flavia Mulè1, Antonella Amato, Rosa Serio

  • 1Dipartimento di Biologia cellulare e dello Sviluppo, Laboratorio di Fisiologia generale, Università di Palermo, Viale delle Scienze, 90128 Palermo, Italy. fmule@unipa.it

Insights

This study reveals that both NK(1) and NK(2) receptors in the mouse colon contribute to contractions. NK(1) receptors are on neurons and muscle, while NK(2) receptors are solely on muscle cells, leading to additive responses.

Area of Science:

  • Gastroenterology
  • Neuropharmacology
  • Cellular Physiology

Background:

  • Tachykinins, such as substance P and neurokinin A, play roles in gastrointestinal function.
  • Neurokinin (NK) receptors, specifically NK1 and NK2, are implicated in modulating colonic motility.
  • Understanding the precise roles and localization of these receptors is crucial for comprehending colonic mechanical activity.

Purpose of the Study:

  • To investigate the functional roles of endogenous and exogenous activation of NK1 and NK2 receptors in mouse proximal colon mechanical activity.
  • To determine the localization of NK1 and NK2 receptors within the colonic tissue.
  • To elucidate the contribution of these receptors to nonadrenergic noncholinergic (NANC) contractions.

Main Methods:

  • In vitro experiments using isolated mouse proximal colon segments.
  • Measurement of intraluminal pressure changes to assess mechanical activity.
  • Pharmacological manipulation using selective receptor agonists and antagonists (SR140333 for NK1, SR48968 for NK2), electrical field stimulation, tetrodotoxin, atropine, and L-NAME.

Main Results:

  • Electrical field stimulation induced NANC contractions, significantly reduced by NK1 and NK2 antagonists, with NK2 antagonists showing greater efficacy.
  • Selective NK1 receptor agonist ([Sar(9), Met(O(2))(11)]-substance P) caused a biphasic response (contraction then inhibition), while the selective NK2 agonist ([beta-Ala(8)]-neurokinin A (4-10)) induced concentration-dependent contraction.
  • NK1 receptor activation involved cholinergic and nitrergic neurons and smooth muscle cells, whereas NK2 receptor activation appeared restricted to smooth muscle cells.

Conclusions:

  • Both NK1 and NK2 receptors are activated by endogenous tachykinins in the mouse colon, contributing additively to mechanical activity.
  • NK1 receptors are located on cholinergic and nitrergic neurons, as well as smooth muscle cells.
  • NK2 receptors are exclusively found on smooth muscle cells, mediating contractions.

Related Concept Videos

Enteric Nervous System: Regulation of GI Motor Activity01:11

Enteric Nervous System: Regulation of GI Motor Activity

The Enteric Nervous System (ENS) plays a pivotal role in regulating gastrointestinal or GI motor activity. This complex network of nerves, deeply embedded within the gut wall, responds to changes in the gut environment and receives input from both the autonomic nervous system and the central nervous system. By doing so, the ENS operates various programs tailored to the body's nutritional status and needs.
During periods of fasting, the ENS initiates the migrating myoelectric complex, a program...
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Parasympathetic Signaling01:30

Parasympathetic Signaling

Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...